ResearcherUniversity Medical Center Hamburg-EppendorfActive in the last 2 years
Joseph Tintelnot
Matched on ORCID iD 0000-0003-4619-9433; OpenAlex author ID A5027677462. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2023: 2 papers · 2024: 1 paper · 2025: 1 paper
Papers 4
- Author Correction: Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Co-author DOI 10.1038/s41586-025-08979-z↗
- Roles of microbiota in pancreatic cancer development and treatment. First author DOI 10.1080/19490976.2024.2320280↗
- Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Co-author DOI 10.1038/s41586-023-05728-y↗
- Peripheral and Portal Venous KRAS ctDNA Detection as Independent Prognostic Markers of Early Tumor Recurrence in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1093/clinchem/hvac214↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Nicola Gagliani · 3 shared papers, 2023–2025 · strength 0.65
- Paper Roles of microbiota in pancreatic cancer development and treatment. DOI 10.1080/19490976.2024.2320280↗
- Paper Author Correction: Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. DOI 10.1038/s41586-025-08979-z↗
- Paper Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. DOI 10.1038/s41586-023-05728-y↗
- Marianne Sinn · 3 shared papers, 2023–2025 · strength 0.43
- Paper Author Correction: Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. DOI 10.1038/s41586-025-08979-z↗
- Paper Peripheral and Portal Venous KRAS ctDNA Detection as Independent Prognostic Markers of Early Tumor Recurrence in Pancre… DOI 10.1093/clinchem/hvac214↗
- Paper Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. DOI 10.1038/s41586-023-05728-y↗
- Jakob Robert Izbicki · 3 shared papers, 2023–2025 · strength 0.43
- Paper Author Correction: Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. DOI 10.1038/s41586-025-08979-z↗
- Paper Peripheral and Portal Venous KRAS ctDNA Detection as Independent Prognostic Markers of Early Tumor Recurrence in Pancre… DOI 10.1093/clinchem/hvac214↗
- Paper Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. DOI 10.1038/s41586-023-05728-y↗
- Faik Güntac Uzunoglu · 3 shared papers, 2023–2025 · strength 0.43
- Paper Author Correction: Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. DOI 10.1038/s41586-025-08979-z↗
- Paper Peripheral and Portal Venous KRAS ctDNA Detection as Independent Prognostic Markers of Early Tumor Recurrence in Pancre… DOI 10.1093/clinchem/hvac214↗
- Paper Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. DOI 10.1038/s41586-023-05728-y↗
- Mariana Santos Cruz · 1 shared paper, 2024 · strength 0.36
- Danmei Zhang · 2 shared papers, 2023–2025 · strength 0.29
- Leonie Konczalla · 2 shared papers, 2023–2025 · strength 0.29
- Marija Trajkovic‐Arsic · 2 shared papers, 2023–2025 · strength 0.29
- Jens Thomas Siveke · 2 shared papers, 2023–2025 · strength 0.29
- Alec C. Kimmelman · 2 shared papers, 2023–2025 · strength 0.29
- Cenap Güngör · 2 shared papers, 2023–2025 · strength 0.29
- Stefan Hubert Boeck · 2 shared papers, 2023–2025 · strength 0.29
- Harriet Wikman · 1 shared paper, 2023 · strength 0.14
- Christine Nitschke · 1 shared paper, 2023 · strength 0.14
- Louisa Stern · 1 shared paper, 2023 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.